Processa Pharmaceuticals (PCSA) EBITDA Margin Growth (3y) (2015 - 2016)
Processa Pharmaceuticals (PCSA) EBITDA Margin Growth (3y) (2015 - 2016) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - | -2,649.00 |
| 10 | Processa Pharmaceuticals | 5.89 Mn | 5.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 266,218.00 |
| Dec 31, 2015 | 119,974.00 |
| Sep 30, 2015 | 44,819.00 |
| Jun 30, 2015 | -901,696.00 |